Kim R Tsuchimoto Monopar Therapeutics (MNPR) insider trading activity

MNPR Quotes by TradingView

Kim R Tsuchimoto is Chief Financial Officer of Monopar Therapeutics. Currently has a direct ownership of 57,429 shares of MNPR, which is worth approximately $840,186. The most recent transaction as insider was on Jan 01, 2022, when has been sold 1,231 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.4K
0% 3M change
51.18% 12M change
Total Value Held $840,186

Kim R Tsuchimoto Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 01 2022
BUY
Exercise of conversion of derivative security
-
1,231 Added 18.51%
5,420 Common Stock
Dec 31 2021
SELL
Payment of exercise price or tax liability
$1,608 $3.21 p/Share
501 Reduced 10.68%
4,189 Common Stock
Dec 31 2021
BUY
Exercise of conversion of derivative security
-
1,221 Added 20.66%
4,690 Common Stock
Sep 30 2021
SELL
Payment of exercise price or tax liability
$2,060 $4.87 p/Share
423 Reduced 10.87%
3,469 Common Stock
Sep 30 2021
BUY
Exercise of conversion of derivative security
-
1,221 Added 23.88%
3,892 Common Stock
Jun 30 2021
SELL
Payment of exercise price or tax liability
$4,847 $5.89 p/Share
823 Reduced 23.55%
2,671 Common Stock
Jun 30 2021
BUY
Exercise of conversion of derivative security
-
2,442 Added 41.14%
3,494 Common Stock
Jan 01 2021
SELL
Payment of exercise price or tax liability
$3,084 $6.12 p/Share
504 Reduced 32.39%
1,052 Common Stock
Jan 01 2021
BUY
Exercise of conversion of derivative security
-
1,231 Added 44.17%
1,556 Common Stock
KRT

Kim R Tsuchimoto

Chief Financial Officer
Wilmette, IL

Track Institutional and Insider Activities on MNPR

Follow Monopar Therapeutics and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MNPR shares.

Notify only if

Insider Trading

Get notified when an Monopar Therapeutics insider buys or sells MNPR shares.

Notify only if

News

Receive news related to Monopar Therapeutics

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MNPR